Stryker (SYK) Current Deferred Tax Assets (2009 - 2015)
Stryker's (SYK) quarterly Current Deferred Tax Assets came in at $933.0 million in Q3 2015, down 5.47% year-over-year from $987.0 million in Q3 2014, and down 2.3% quarter-over-quarter from $955.0 million in Q2 2015.
Analysis
Stryker (SYK) Current Deferred Tax Assets (2009 - 2015) Analysis & Trends
Stryker (SYK) has reported Current Deferred Tax Assets for 7 consecutive years, with $933.0 million the latest figure, recorded in Q3 2015.
- On a quarterly basis, Current Deferred Tax Assets fell 5.47% year-over-year to $933.0 million in Q3 2015; TTM through Sep 2015 was $933.0 million, a 5.47% decrease from a year earlier, with the FY2014 full-year figure at $989.0 million, up 12.39% from the prior year.
- Current Deferred Tax Assets was $933.0 million for Q3 2015 at Stryker, down from $955.0 million in the prior quarter.
- Over five years, Current Deferred Tax Assets peaked at $989.0 million in Q4 2014 and troughed at $757.0 million in Q3 2013.
- A 5-year average of $871.0 million and a median of $880.0 million in 2013 frame the typical range for Current Deferred Tax Assets.
- Across the five-year window, Current Deferred Tax Assets slipped 11.98% in 2013 and surged 30.38% in 2014, its largest moves.
- Over 5 years, Current Deferred Tax Assets stood at $777.0 million in 2011, then gained by 4.38% to $811.0 million in 2012, then gained by 8.51% to $880.0 million in 2013, then rose by 12.39% to $989.0 million in 2014, then retreated by 5.66% to $933.0 million in 2015.
- The last three Current Deferred Tax Assets figures came in at $933.0 million (Q3 2015), $955.0 million (Q2 2015), and $894.0 million (Q1 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 177.98 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.46 Bn | 119.24 Bn | 1.96 Bn |
| 3 | Medtronic | 118.00 Bn | 109.18 Bn | 6.34 Bn |
| 4 | Stryker | 106.11 Bn | 102.64 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.60 Bn | 66.06 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.52 Bn | 45.27 Bn | 1.35 Bn |
| 7 | Alcon | 33.91 Bn | 32.45 Bn | 1.68 Bn |
| 8 | Dexcom | 32.11 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 21.08 Bn | 20.59 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.24 Bn | 17.83 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 933.00 Mn |
| Jun 30, 2015 | 955.00 Mn |
| Mar 31, 2015 | 894.00 Mn |
| Dec 31, 2014 | 989.00 Mn |
| Sep 30, 2014 | 987.00 Mn |
| Jun 30, 2014 | 941.00 Mn |
| Mar 31, 2014 | 918.00 Mn |
| Dec 31, 2013 | 880.00 Mn |
| Sep 30, 2013 | 757.00 Mn |
| Jun 30, 2013 | 781.00 Mn |
| Mar 31, 2013 | 791.00 Mn |
| Dec 31, 2012 | 811.00 Mn |
| Sep 30, 2012 | 860.00 Mn |
| Jun 30, 2012 | 791.00 Mn |
| Dec 31, 2011 | 777.00 Mn |
| Dec 31, 2010 | 653.20 Mn |
| Dec 31, 2009 | 602.20 Mn |